Nrf2 is crucial for the down-regulation of Cyp7a1 induced by arachidonic acid in Hepg2 cells.

[1]  Shang-Rong Xu,et al.  NF-E2-related factor 2 deletion facilitates hepatic fatty acids metabolism disorder induced by high-fat diet via regulating related genes in mice. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[2]  Hironari Akasaka,et al.  Identification of the two-phase mechanism of arachidonic acid regulating inflammatory prostaglandin E2 biosynthesis by targeting COX-2 and mPGES-1. , 2016, Archives of biochemistry and biophysics.

[3]  Xiu-dong Wang,et al.  Impact of high-fat diet on liver genes expression profiles in mice model of nonalcoholic fatty liver disease. , 2016, Environmental toxicology and pharmacology.

[4]  Hironari Akasaka,et al.  IDENTIFICATION OF THE TWO-PHASE MECHANISM OF ENDOGENOUS OMEGA-6 FATTY ACID, ARACHIDONIC ACID, REGULATING VASCULAR INFLAMMATION BY TARGETING CYCLOOXYGENASE-2 AND MICROSOMAL PROSTAGLANDIN E2 SYNTHASE-1 , 2016 .

[5]  Matthew McMillin,et al.  Bile Acid Signaling Is Involved in the Neurological Decline in a Murine Model of Acute Liver Failure. , 2016, The American journal of pathology.

[6]  J. Kemper,et al.  Farnesoid X receptor–induced lysine‐specific histone demethylase reduces hepatic bile acid levels and protects the liver against bile acid toxicity , 2015, Hepatology.

[7]  Yong-hui Shi,et al.  Role of thyroid hormone homeostasis in obesity-prone and obesity-resistant mice fed a high-fat diet. , 2015, Metabolism: clinical and experimental.

[8]  M. Honda,et al.  Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[9]  I. de Sio,et al.  Focus on emerging drugs for the treatment of patients with non-alcoholic fatty liver disease. , 2014, World journal of gastroenterology.

[10]  C. Klaassen,et al.  Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice[S] , 2014, Journal of Lipid Research.

[11]  Chan-Min Liu,et al.  Puerarin Attenuates Carbon Tetrachloride‐Induced Liver Oxidative Stress and Hyperlipidaemia in Mouse by JNK/c‐Jun/CYP7A1 Pathway , 2014, Basic & clinical pharmacology & toxicology.

[12]  H. Cortez‐Pinto,et al.  Non-alcoholic fatty liver disease: what the clinician needs to know. , 2014, World journal of gastroenterology.

[13]  J. Hayes,et al.  Susceptibility of Nrf2-Null Mice to Steatohepatitis and Cirrhosis upon Consumption of a High-Fat Diet Is Associated with Oxidative Stress, Perturbation of the Unfolded Protein Response, and Disturbance in the Expression of Metabolic Enzymes but Not with Insulin Resistance , 2014, Molecular and Cellular Biology.

[14]  T. Ceska,et al.  Binding Mode and Structure–Activity Relationships around Direct Inhibitors of the Nrf2–Keap1 Complex , 2014, ChemMedChem.

[15]  T. Ikeda,et al.  Role of Nrf2 in the alteration of cholesterol and bile acid metabolism-related gene expression by dietary cholesterol in high fat-fed mice , 2014, Journal of clinical biochemistry and nutrition.

[16]  Masayuki Yamamoto,et al.  Possible involvement of nuclear factor erythroid 2-related factor 2 in the gene expression of Cyp2b10 and Cyp2a5 , 2014, Redox biology.

[17]  Xiaomin Luo,et al.  Identification of 15d-PGJ2 as an antagonist of farnesoid X receptor: Molecular modeling with biological evaluation , 2013, Steroids.

[18]  G. Hassanzadeh,et al.  Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARα and SREBP-1. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[19]  M. Yamada,et al.  Nrf2 Activators Attenuate the Progression of Nonalcoholic Steatohepatitis–Related Fibrosis in a Dietary Rat Model , 2013, Molecular Pharmacology.

[20]  J. Manautou,et al.  Nrf2: A Potential Target for New Therapeutics in Liver Disease , 2012, Clinical pharmacology and therapeutics.

[21]  Zhen-Ao Zhao,et al.  Arachidonic acid regulation of the cytosolic phospholipase A 2α/cyclooxygenase-2 pathway in mouse endometrial stromal cells. , 2012, Fertility and sterility.

[22]  Yi‐Chen Chen,et al.  Preventive effects of taurine on development of hepatic steatosis induced by a high-fat/cholesterol dietary habit. , 2011, Journal of agricultural and food chemistry.

[23]  C. Glass,et al.  Macrophages, oxysterols and atherosclerosis. , 2010, Circulation journal : official journal of the Japanese Circulation Society.

[24]  J. Hakkola,et al.  Cytochrome P450 2A5 constitutive expression and induction by heavy metals is dependent on redox-sensitive transcription factor Nrf2 in liver. , 2010, Chemical research in toxicology.

[25]  R. Green,et al.  628 Chronic High Cholesterol Feeding Suppresses Hepatic Cholesterol 7α Hydroxylase (CYP7A1) Expression in Mice Associated With Induction of Tumor Necrosis Factor Alpha (TNFα) , 2010 .

[26]  J. Hardwick,et al.  PPAR/RXR Regulation of Fatty Acid Metabolism and Fatty Acid ω-Hydroxylase (CYP4) Isozymes: Implications for Prevention of Lipotoxicity in Fatty Liver Disease , 2010, PPAR research.

[27]  Wei Zhang,et al.  Tumor necrosis factor-alpha accelerates apoptosis of steatotic hepatocytes from a murine model of non-alcoholic fatty liver disease. , 2010, Biochemical and biophysical research communications.

[28]  G. Fredman,et al.  Diabetes-Induced Oxidative Stress Is Mediated by Ca2+-Independent Phospholipase A2 in Neutrophils , 2010, The Journal of Immunology.

[29]  D. Harrison,et al.  Age-Accelerated Atherosclerosis Correlates With Failure to Upregulate Antioxidant Genes , 2009, Circulation research.

[30]  N. Nieto,et al.  Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor α, reduced glutathione, and transforming growth factor β–dependent mechanisms , 2008, Hepatology.

[31]  N. Mitro,et al.  The pharmacological exploitation of cholesterol 7alpha-hydroxylase, the key enzyme in bile acid synthesis: from binding resins to chromatin remodelling to reduce plasma cholesterol. , 2007, Pharmacology & therapeutics.

[32]  S. Jana,et al.  Molecular mechanisms of cytochrome p450 induction: potential for drug-drug interactions. , 2007, Current protein & peptide science.

[33]  K. Feingold,et al.  Endotoxin, TNF, and IL-1 decrease cholesterol 7 alpha-hydroxylase mRNA levels and activity. , 1996, Journal of lipid research.

[34]  Y. Hannun,et al.  Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C. , 1995, Cellular signalling.

[35]  B. Halliwell,et al.  Lipid peroxidation: its mechanism, measurement, and significance. , 1993, The American journal of clinical nutrition.

[36]  T. Eling,et al.  Analysis of leukotrienes, prostaglandins, and other oxygenated metabolites of arachidonic acid by high-performance liquid chromatography. , 1984, Analytical biochemistry.

[37]  J. Chiang,et al.  Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[38]  J. Chiang,et al.  HNF4 and COUP-TFII interact to modulate transcription of the cholesterol 7alpha-hydroxylase gene (CYP7A1). , 2000, Journal of lipid research.